The antitumor activity was mediated by ROS production at 630 nm on NIR irradiation and caspase-3-mediated intratumoral release of MT, thereby evoking an intense CD8+ T cell-induced immune response in lung cancer cells. Here, CD8A is linked to lung cancer.